Neptune Wellness Solutions Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Neptune Wellness Solutions şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-212,513,525.0%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-212,513,525.0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Neptune Wellness Solutions to divest cannabis assets for C$5.15M

Oct 17

Neptune Wellness launches $6M registered direct offering and concurrent private placement

Oct 06

Neptune Wellness Solutions trades higher on licensing agreement between Sprout Foods and CoComelon

Jun 09

Neptune Wellness' cannabis brand PanHash now available in Quebec

May 27

Neptune Wellness inks supply agreement with AGLC, expands Canadian footprint

Apr 28

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: NEPT.F şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: NEPT.F şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Neptune Wellness Solutions Piyasaya Karşı Temettü Getirisi

NEPT.F temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (NEPT.F)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Personal Products)	3.0%
Analist tahmini (NEPT.F) (3 yıla kadar)	n/a

Önemli Temettü: NEPT.F şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, NEPT.F şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: NEPT.F şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: NEPT.F herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Neptune Wellness Solutions Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Neptune Wellness Solutions Inc. Appoints Michael De Geus as Interim President and Cedrick Billequey as Interim COO

Neptune Wellness Solutions Inc.(OTCPK:NEPT.F) dropped from NASDAQ Composite Index

Neptune Wellness Solutions Inc. to Report Q3, 2024 Results on Feb 16, 2024

Neptune Wellness Solutions Inc. announced delayed 10-Q filing

Neptune Wellness Announces Receipt of Nasdaq Delisting Notice and Intention to Appeal

Neptune Wellness Solutions Inc. (NasdaqCM:NEPT) entered into a non-binding Letter of Intent to acquire Datasys Group Inc. approximately $110 million.

Neptune Wellness Solutions Inc. Announces Completed Settlement of Class Action Lawsuit

Neptune Wellness Solutions Inc. announced delayed 10-Q filing

Neptune Wellness Solutions Inc. Announces CFO Changes

Neptune Wellness Solutions Inc. announced delayed annual 10-K filing

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $4 million.

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $4 million.

Neptune Wellness Solutions Inc. announced delayed 10-Q filing

Neptune Wellness Solutions Announces Receipt of NASDAQ Notification

Neptune Wellness Solutions Inc. Revises Revenue Guidance for the Second Quarter of Fiscal Year 2023

Neptune Wellness Solutions Inc. announced delayed 10-Q filing

PurCann Pharma Inc. completed the acquisition of Cannabis Assets of Neptune Wellness Solutions Inc. for CAD 5.2 million.

Neptune Wellness Solutions Inc. Reaches Settlement in Shareholder Class Action Litigation

PurCann Pharma Inc. entered into a binding agreement to acquire Cannabis Assets of Neptune Wellness Solutions Inc. for approximately CAD 6 million.

PurCann Pharma Inc. entered into a binding agreement to acquire Cannabis Assets of Neptune Wellness Solutions Inc. for CAD 5.15 million.

Neptune Wellness Solutions to divest cannabis assets for C$5.15M

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $6.000002 million.

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $6.000002 million.

Neptune Wellness launches $6M registered direct offering and concurrent private placement

Neptune Wellness Solutions Inc. Announces Impairment Charges for the Three Months Ended June 30, 2022

Neptune Wellness Solutions Inc. to Report Q1, 2023 Results on Aug 15, 2022

Neptune Wellness Solutions Announces Voluntary Delisting from Toronto Stock Exchange

Neptune Wellness announces voluntary delisting from TSX

Neptune Wellness Solutions Inc., Annual General Meeting, Sep 27, 2022

Neptune Wellness Solutions GAAP EPS of -$17.50, revenue of $48.8M

Neptune Wellness Solutions Inc. announced delayed amended 10-K filing

Neptune Wellness Solutions Inc. announced delayed annual 10-K filing

Neptune Wellness Solutions Inc. to Report Q4, 2022 Results on Jun 29, 2022

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $5.000002 million.

Neptune Wellness Solutions Inc. Appoints Raymond Silcock as Executive Vice President, Effective July 25, 2022

Neptune Wellness Solutions Inc. Launches New CPG-Focused Strategic Plan to Improve Path to Profitability

High number of new and inexperienced directors

Neptune Wellness Solutions Inc. Appoints Phil Sanford to Board of Directors and Audit Chair

Neptune Wellness Expands Popular Mood Ring Portfolio with New Cannabis Strains

Neptune Wellness: New Valuation As The Stock Bounces Back From The Bottom

Neptune Wellness Launches Forest Remedies Multi-Omega 3-6-9 Supplements in 340+ Sprouts Farmers Market Stores Across U.S

Neptune Granted 180-Day Extension to Meet Nasdaq Minimum Bid Requirement

President recently bought US$384k worth of stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Neptune Wellness Solutions Inc. Announces Management Changes

Neptune Wellness Solutions Inc. to Report Q3, 2022 Results on Feb 10, 2022

Neptune Wellness Solutions Inc. Extends Mood Ring Product Line with In-Demand Pre-Rolls Launching in Ontario and Alberta

Second quarter 2022 earnings released: CA$0.076 loss per share (vs CA$0.20 loss in 2Q 2021)

High number of new directors

High number of new directors

High number of new directors

Neptune Wellness Solutions Announces Receipt of Nasdaq Notification

Independent Director Jane Pemberton has left the company

Independent Director Frank Rochon has left the company

Neptune Launches Forest Remedies Plant-Based Omega 3-6-9 Supplements

Independent Chairman recently bought US$79k worth of stock

Neptune Wellness Solutions Inc. Provides Revenue Guidance for the First Quarter Ended June 30, 2021

Full year 2021 earnings released: CA$1.38 loss per share (vs CA$0.68 loss in FY 2020)

Neptune Wellness Solutions Inc. Announces Impairment Charges for the Fourth Quarter Ended March 31, 2021

Neptune Wellness Solutions Inc. Launches Three New Mood Ring Branded Cannabis Products

Neptune Wellness Solutions trades higher on licensing agreement between Sprout Foods and CoComelon

Neptune Wellness Solutions Inc. Announces the Launch of Panhashtm in Quebec

Neptune Wellness' cannabis brand PanHash now available in Quebec

Independent Director has left the company

Neptune Wellness inks supply agreement with AGLC, expands Canadian footprint

Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Neptune Wellness Solutions, Inc., of Class Action Lawsuit and Upcoming Deadline

Glancy Prongay & Murray LLP Announces the Filing of Securities Class Action on Behalf of Neptune Wellness Solutions Inc. Investors

Pomerantz LLP Announces the Filing of Class Action Against Neptune Wellness Solutions, Inc

Neptune Wellness Solutions, Inc. Enters into Letter of Intent with Société québécoise du cannabis

New 90-day low: US$1.40

Groundbreaking Research Finds Neptune's Patented Maxsimil® Fish Oil Up to 3.5 Times More Absorbable Than Standard Fish Oil

Neptune Wellness Solutions Inc. Announces Cannabis Brand Mood Ring™ Is Now Available Through the Ontario Cannabis Store

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $55 million.

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute with Azpa Pharmaceuticals Pty. Ltd

Neptune Wellness Solutions Inc. has completed a Follow-on Equity Offering in the amount of $18.6 million.